Oct 3 Jazz Pharmaceuticals Plc :
* Expects to complete submission of NDA by early 2017, and will request a priority review.
* Initiates rolling NDA submission for Vyxeos (CPX-351) expects to complete NDA submission by early 2017 Source text for Eikon: Further company coverage:
BRIEF-Wiley raises quarterly cash dividend for 24th consecutive year
* Wiley raises quarterly cash dividend for 24th consecutive year
BRIEF-goeasy Ltd announces renewal of normal course issuer bid
* goeasy Ltd - Pursuant to NCIB, co proposes to purchase, up to an aggregate of 300,000 shares, about 4% of goeasy's public float as of June 13, 2017